Business
Bionova Scientific® opens new pDNA facility in Texas to support rapidly growing biopharma industry
HOUSTON, August 12, 2025--Bionova Scientific has announced the opening of a 10,000 square-foot state-of-the-art pDNA development and production facility in The Woodlands.
About this update from Asahi Kasei Corporation
[{"type":"image","alt":"Research Forest in The Woodlands, Texas.","displaySize":"","headline":null,"caption":"Research Forest in The Woodlands, Texas.","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":360,"url":"https://media.zenfs.com/en/business-wire.com/0578a912f6361fcac970ed451d4f0feb"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/x999YlF4LpLN2uijMRFTIw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTcyMDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/0578a912f6361fcac970ed451d4f0feb","width":480,"height":360}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":4999,"height":683,"url":"https://media.zenfs.com/en/business-wire.com/baae41e987d462f034f72efc63acc922"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/gIO0hFWC16.217DlDWCmow--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTEzMTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/baae41e987d462f034f72efc63acc922","width":960,"height":131},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/uFLdr5X550WxYFWVv6t9Xw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zMjg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/baae41e987d462f034f72efc63acc922","width":1200,"height":164}}},{"type":"text","content":"HOUSTON, August 12, 2025--(BUSINESS WIRE)--Bionova Scientific®, a full-service biologics contract development and manufacturing organization (CDMO) and subsidiary of global conglomerate Asahi Kasei, has announced the opening of a 10,000 square-foot state-of-the-art plasmid DNA (pDNA) development and production facility in The Woodlands, Texas.","length":345,"tagName":"p"},{"type":"text","content":"Located less than 30 miles north of Houston, Texas, the new facility designs, develops and manufactures research-grade pDNA materials to support the cell and gene therapy field. With the global pharmaceutical market anticipated to reach almost $3 trillion by 2033, Bionova Scientific has positioned itself to effortlessly accommodate the market’s rapid growth. Enabled by the new Texas facility, the company will expand its offerings beyond mammalian protein production and provide clinical to commercial-scale Current Good Manufacturing Practice (CGMP) production of pDNA by Q4 2025.","length":584,"tagName":"p"},{"type":"text","content":"Plasmid DNA ...